Wija Oortwijn
RAND Corporation
Environmental resource managementHealth careHealth technologyHealth policyMedicine
What is this?
Publications 34
#1Brian Godman (Strathclyde Institute of Pharmacy and Biomedical Sciences)H-Index: 39
#2Eduard DiogeneH-Index: 1
Last. Björn WettermarkH-Index: 35
view all 11 authors...
Abstract: Countries struggling to fund new premium priced medicines with ever increasing prices. In addition, substantial savings as medicines lose their patents. This requires co-ordinated approaches. Models are being developed centring on three pillars: pre-launch including horizon scanning; peri-launch including P & R/ risk sharing; post-launch including assessing effectiveness. This will continue to enable access to safe, effective and affordable medicines. Introduction: Countries are strugg...
1 CitationsSource
#1Philip Wahlster (University of Bremen)H-Index: 4
#2Louise Brereton (University of Sheffield)H-Index: 12
Last. Ansgar Gerhardus (University of Bremen)H-Index: 12
view all 12 authors...
OBJECTIVES Current health technology assessment (HTA) is not well equipped to assess complex technologies as insufficient attention is being paid to the diversity in patient characteristics and preferences, context, and implementation. Strategies to integrate these and several other aspects, such as ethical considerations, in a comprehensive assessment are missing. The aim of the European research project INTEGRATE-HTA was to develop a model for an integrated HTA of complex technologies. METHODS...
4 CitationsSource
Background: In recent years, there has been a surge in the development of frameworks to assess the value of different types of health technologies to inform healthcare resource allocation. The reasons for, and the potential of, these value frameworks were discussed during the 2017 Health Technology Assessment International (HTAi) Policy Forum Meeting. Methods: This study reflects the discussion, drawing on presentations from invited experts and Policy Forum members, as well as a background paper...
6 CitationsSource
#1Brian Godman (Strathclyde Institute of Pharmacy and Biomedical Sciences)H-Index: 39
#2Wija OortwijnH-Index: 11
Last. Jeroen van der TuinH-Index: 2
view all 8 authors...
Each patient in the European Union has a right of access to care. National governments face the challenge to balance resources against healthcare demand to ensure that populations enjoy equitable access to effective, affordable and sustainable healthcare. This study describes the main challenges with regard to access to affordable medicines, including Research & Development, pricing and reimbursement of medicines and the influence of the economic crisis. Potential policy options to tackle these ...
2 Citations